BSECompany Update6 Oct 2026 · 6 Oct 2026, 06:04 pm

Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended September 30, 2026

Clinitech Laboratory Ltd · 544220

✦ AI Summary

Clinitech Laboratory Ltd has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming that the regulation is not applicable to the company as all its shares are in demat form and no requests for rematerialisation were received during the quarter ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Clinitech Laboratory Ltd - 544220 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Attachments (1)

📄

49d96287-a645-4534-86e6-05e8b1547e14.pdf

pdf

Download →
View document text
Date: October 06, 2026. Asst. General Manager, Dept. of Corporate Services, BSE Limited 1st Floor, P.J. Towers, Dalal Street, Fort, Mumbai: 400001. Sub: Disclosure under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Reference: CLINITECH LABORATORY LIMITED (CTLLAB) Scrip Code: 544220. Dear Sir, Please find enclosed the disclosure under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, as amended, received from the Bigshare Services Pvt. Ltd., Registrar and Transfer Agent (RTA) for the quarter ended September 30, 2026, for your kind perusal and Records. Kindly take the note of the same. Thanking you, Yours faithfully, For CLINITECH LABORATORY LIMITED Jagdish Umakant Nayak Chairman and Managing Director DIN: 00646672 Bigshare Services Pvt. Ltd. Ref No. BSS/Reg 74(5)/2026 Date: 05/10/2026 CLINITECH LABORATORY LIMITED AL - 1 / 545, SECTOR 16, OPPOSITE RADHIKABAI MEGHE VIDYALAYA, AIROLI, THANE, NAVI MUMBAI 400708 Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026. Dear Sir, With reference to the captioned regulation, we hereby confirm that the said Regulation is not applicable to the Company, as the entire holding of the Company’s shares are in demat form, and we have not received any request from any members of the Company for rematerialisation during the quarter ended on 30th September 2026. We request you to kindly take note of the above in your records. Thanking you, Yours faithfully, For Bigshare Services Pvt. Ltd., Sandeep More Authorised Signatory CIN : U99999MH1994PTC076534 Regd. Office: Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road, Andheri (East) Mumbai - 400 093. Tel. : +9122 6263 8200 • Fax : +9122 6263 8299 • Email : info@bigshareonline.com • Website : www.bigshareonline.com